Furthermore, propionate, as a histone deacetylase (HDAC) inhibitor, blocks histone deacetylation, leading to chromatin relaxation and the transcriptional activation of pro-apoptotic genes such as HECT domain E3 ubiquitin protein ligase 2 (HECTD2), ultimately inducing apoptosis in cancer cells. Here, HECTD2 is linked to cancer.